Please login to the form below

Not currently logged in
Email:
Password:

Breo Ellipta

This page shows the latest Breo Ellipta news and features for those working in and with pharma, biotech and healthcare.

Advair generics and acquisitions to hit GSK in 2019

Advair generics and acquisitions to hit GSK in 2019

Combined sales of all Ellipta products rose 29% to £2.04bn ($2.64bn). ... However the tough US market took a bite out of Breo Ellipta, which saw sales decline (3% AER, 1% CER) because of pricing pressure, despite strong volume growth.

Latest news

  • Sovaldi pushes Gilead to the top of US pharma list Sovaldi pushes Gilead to the top of US pharma list

    The London-based firm has also failed to increase market share for its next-gen versions of Advair - namely Breo, Ellipta and Anoro Ellipta - which had combined sales last year of

  • China weighs heavy on GSK figures in Q3 China weighs heavy on GSK figures in Q3

    There were also launches for melanoma drugs Tafinlar (dabrafenib) and Mekinist (trametinib), Tivicay (dolutegravir) for HIV via GSK's ViiV joint venture with Pfizer and Shionogi, and new COPD therapy Breo ... Ellipta (fluticasone furoate and vilanterol).

  • GSK wins US approval for Seretide successor Breo Ellipta GSK wins US approval for Seretide successor Breo Ellipta

    Breo Ellipta will help patients breathe better day-to-day and reduce the risk of future exacerbations, with a once-daily inhalation.”. ... The partners plan to launch Breo Ellipta in the US during the third quarter of this year.

  • GSK buoyed by FDA panel backing for Advair successor GSK buoyed by FDA panel backing for Advair successor

    Breo, delivered once-daily using a new Ellipta inhaler, is seen as a critical drug for GSK as it tries to defend its asthma and COPD franchise dominated by twice-daily ... Breo Ellipta (which will be sold as Relvar in Europe) is being positioned by GSK

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ahair@onyxhealth.com

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...